10/4/2016 FROM WAAAH! TO AAAH! An Evidence-Based Update to the - - PDF document

▶
10 4 2016
SMART_READER_LITE
LIVE PREVIEW

10/4/2016 FROM WAAAH! TO AAAH! An Evidence-Based Update to the - - PDF document

Aug 19, 2023 405 likes •600 views

10/4/2016 FROM WAAAH! TO AAAH! An Evidence-Based Update to the Well-Child Check Madeleine Sanford, FNP OHSU Department of Family Medicine 1 10/4/2016 AAP Periodicity Schedule Objectives For each well-child check topic, the participant

slide-1
SLIDE 1

10/4/2016 1

FROM WAAAH! TO AAAH!

An Evidence-Based Update to the Well-Child Check

Madeleine Sanford, FNP OHSU Department of Family Medicine

slide-2
SLIDE 2

10/4/2016 2

AAP Periodicity Schedule

Objectives

For each well-child check topic, the participant will be able to:

WCC Screening Update Summarize the epidemiology and risk factors

Describe the impact of the problem

Integrate the recommendation into practice

Choose Your Own Adventure!

Well Child Check Topic Choices

Obesity/ Dyslipidemia Oral Health Screening/ Topical Fluoride in Office Adolescent Depression/ Substance Abuse

Iron Deficiency / Lead Exposure

Developmental / Autism Screening Matters

slide-3
SLIDE 3

10/4/2016 3

3 2 1 7 6 4 5 10 15 20 25 Age 0-2 Age 3-5 Age 6-11 IDA Iron Deficiency

Iron Deficiency: The Problem

US Prevalence 10 12 17 20

5 10 15 20 25

% US Children % Iron Deficiency in High Risk Toddlers

Poorer cognition in adulthood SOCIAL

  • Low income
  • Low literacy
  • Race

SPECIAL NEEDS

LEAD EXPOSURE HX PREMATURITY

  • NUTRITION

Breastfeeding > 4 mos without iron

  • Weaning to

milk/ non-iron rich foods

  • Obesity

Risk Factors for Anemia

Anemia Screening

WHEN:

USPSTF: I (insufficient) AAP: 12 months universal, after based on risk factors

HOW:

Hgb <11

slide-4
SLIDE 4

10/4/2016 4

Prevention

Iron Deficiency

  • Preterm

<37 wks

  • Age 2-4 wks 

iron rich foods

Breastfed > ½

Age 4 mos  iron-rich foods

Marginally LBW

Age 8 wks  iron-rich foods

High Risk age 6-12 mos

Grade B Evidence

AAP USP STF AAP AAP

Nutrition counseling Lead Exposure

Why It Matters

Pb >2

ADHD Lower IQ Anti- social CV Effects Motor skills

  • NO safe levels
  • Chelation

doesn’t improve neurocognitive scores

slide-5
SLIDE 5

10/4/2016 5

Lead Exposure in Oregon

The Problem Results for Oregon children screened for lead

<2 64% 2 to 5 22% 5 to 10 12% 10+ 2%

(Oregon Department of Human Services Childhood Lead Poisoning Prevention Program, 2010)

PRE-1978 HOUSING / DAYCARE

MINORITY

PARENTAL / SIBLING LEAD EXPOSURE RECENT IMMIGRANTS

POVERTY Risk Factors for Lead Exposure

Lead Screening / Prevention

WHEN:

USPSTF: I (insufficient) AAP: Risk assessment 6 mos- 6 yrs Medicare: 12 and 24 mos*

PREVENTION / counseling

slide-6
SLIDE 6

10/4/2016 6

Adolescent Depression Screening Adolescent Depression

Suicide is Oregon's number two cause of death among youth

Oregon Health Division (2008)

01 02 03 04 Adolescent Depression

Why It Matters

Girls > Boys

4%-9% of adolescents

(Biros MH et al., 2008)

20% admitted to ED met criteria for depression

poor academic performance, legal problems substance use, early pregnancy, family disruption

Sequelae Most depressed adolescents receive no treatment

slide-7
SLIDE 7

10/4/2016 7

POVERTY

PARENT WITH DEPRESSION

CIGARETTE SMOKING

MAJOR NEGATIVE LIFE EVENT OBESITY Risk Factors for Adolescent Depression

Adolescent Depression Screening

WHEN: USPSTF AAP: Yearly, age 11-21 HOW: PHQ-A

PHQ-A: Same as PHQ-2 with 2 extra questions Just like the PHQ-9, but with 2 extra questions:

slide-8
SLIDE 8

10/4/2016 8

Adolescent Depression Fluoxetine (Prozac) and escitalopram (Lexapro) are approved for use in children.

10 20 30 40 First drank alcohol before age 13 Alcohol in past 30 days 5+ drinks past 31 days Drinking + driving past 30 days Marijuana past 30 d Ever took rx drug that wasn't theirs

% US Teens, 2011

Adolescent Substance Abuse

The Problem

(CDC Youth Risk Behavior Surveillance System, 2011)

Adolescent Substance Abuse Screening

WHEN: USPSTF: I (Insufficient) AAP: Yearly risk assessment age 11-21 HOW: CRAFFT

slide-9
SLIDE 9

10/4/2016 9

Adolescent Substance Abuse Screening

CRAFFT: Car, Relax, Alone, Forget, Friends, Trouble

Adolescent Substance Abuse Screening

CRAFFT: Car, Relax, Alone, Forget, Friends, Trouble

Childhood Obesity

The Problem

  • 17% aged 2 -19 years are obese
  • Improving in 2-5 year age range (13% down to 9%)
  • Higher among Hispanics (22.4%) and non-Hispanic blacks (20.2%) than

among non-Hispanic whites (14.1%).

slide-10
SLIDE 10

10/4/2016 10

GENETIC

  • Self-regulation
  • f food via

FTO gene

PRENATAL SWEET BEVERAGES

  • juice

SEDENTARY

  • Screen time
  • POVERTY

Risk Factors for Pediatric Obesity

Pediatric Obesity Screening / Intervention

WHEN: USPSTF: AAP: Every visit, starting age 2 HOW: BMI

Dyslipidemia Screening

WHEN: USPSTF: AAP: Once age 9-11, again age 17-19 HOW: Direct LDL (non-fasting) BMI

slide-11
SLIDE 11

10/4/2016 11

Dyslipidemia Intervention per AAP

  • <1% qualify for statin
  • Primarily genetic
  • LDL > 190 after 6 mos trial

lifestyle change

  • LDL > 160 with fam hx 1st

degree premature CV disease

  • Lifestyle modification

Oral Health Screening / Topical Fluoride Oral Health: The Problem

slide-12
SLIDE 12

10/4/2016 12

Pediatric Oral Health Screening

WHEN: USPSTF AAP: Risk assessment and visual screen age 6 - 30 mos, refer to dental home by age 1

Oral Health Risk Assessment Topical Fluoride Application

  • 1. Dry teeth w/ gauze
  • 2. Paint fluoride on teeth

Counsel:

  • No food for 1 hr (drinks ok)
  • Soft foods for next meal
  • No sticky foods today
  • Don’t brush teeth today
  • Yellow discoloration fades
slide-13
SLIDE 13

10/4/2016 13

Fluoride

Remineralization of enamel Inhibits demineralization of enamel Makes cariogenic bacteria less able to produce acid from carbohydrates. TOPICAL (most important) Fluoride paste at WCC or at dentist every 3-6 months (CDC Grade IA) Fluoride toothpaste for all (CDC Grade 1A)

– Smear for < 2 – Pea-size age 2-5

SYSTEMIC – age 6 months- 16 years

– CDC Grade I IA evidence fluoride 6 mos-5 yrs, Grade IA 6 -16 yr – ADA & USPSTF Strength of recommendation :B

NO chance of fluorosis after age 6, most likely 15-30 months

CDC Grade I IA evidence fluoride

Why Developmental/ Autism Screening Matters

Jee, et al (2010), Hix-Small (2007)

ASQ

http://agesandstages.com/age-calculator/

slide-14
SLIDE 14

10/4/2016 14

Adjust for prematurity if :

  • Born <37 weeks

and

  • Current age <2

41

35 (score) / 5 (answered) = 7

Scoring ASQ-3

Avoid pass/fail terms

  • “Above Cutoff”
  • “Near Cutoff”
  • “Below Cutoff”
slide-15
SLIDE 15

10/4/2016 15

43

GET CONSENT DURING VISIT SIGN HERE FAX COPY OF ASQ/ MCHAT

Autism Screening Without screening, mean age 1st eval 48 mos, mean age dx 61 mos – Parents usually notice something wrong by 18 mos M-CHAT revised w/ follow-up – TWICE between 16 and 30 months (18 & 24) – Why twice? MCHAT/ MCHAT-R

slide-16
SLIDE 16

10/4/2016 16

MCHAT: Positive Screen

Simultaneously refer to:

– Early Intervention – CDRC

  • COUNSEL PARENTS: 9+ month wait AFTER

family gets paperwork back

– Audiology

slide-17
SLIDE 17

10/4/2016 17

Bibliography

Committee on Childhood Lead Poisoning Prevention. (2012). Low Level Lead Exposure Harms Children: A Renewed Call for Primary Prevention (p. 65) /www.cdc.gov/nceh/lead/acclpp/final_document_030712.pdf American Academy of Pediatrics. (2008). Recommendations for Preventive Pediatric Health Care-- Periodicity

  • Schedule. Retrieved from https://www.aap.org/en-us/professional-resources/practice-

support/Pages/PeriodicitySchedule.aspx Baker, R. D., & Greer, F. R. (2010). Diagnosis and Prevention of Iron Deficiency and Iron-Deficiency Anemia in Infants and Young Children (0–3 Years of Age). Pediatrics, 126(5), 1040–1050. http ://doi.org/10.1542/peds.2010-2576 Biros MH, Hick K, Cen Y, & et al. (2008). Occult depressive symptoms in adolescent emergency department

  • patients. Archives of Pediatrics & Adolescent Medicine, 162(8), 769–773. http://do

i.org/10.1001/archpedi.162.8.769 Brotanek, J. M., Gosz, J., Weitzman, M., & Flores, G. (2007). Iron Deficiency in Early Childhood in the United States: Risk Factors and Racial/Ethnic Disparities. Pediatrics, 120(3), 568–575. http://doi.

  • rg/10.1542/peds.2007-0572

Brotanek JM, Gosz J, Weitzman M, & Flores G. (2008). Secular trends in the prevalence of iron deficiency among US toddlers, 1976-2002. Archives of Pediatrics & Adolescent Medicine, 162(4), 374–381. http://doi.org/10.1001/archpedi.162.4.374 CDC National Center for Environmental Health. (2013). CDC - Lead - State and Local Programs - Oregon Data, Statistics and Surveillance. ://www.cdc.gov/nceh/lead/data/state/ordata.htm Centers for Disease Control and Prevention. (2002). Iron Deficiency --- United States, 1999--2000. MMWR Weekly, 51(40), 897–899. Committee on Environmental Health. (2005). Lead Exposure in Children: Prevention, Detection, and

  • Management. Pediatrics, 116(4), 1036–1046. http://www.cdc.gov/nchs/data/databriefs/db191.htm

Bibliography, continued

Committee on Substance Abuse. (2011). Substance Use Screening, Brief Intervention, and Referral to Treatment for

  • Pediatricians. Pediatrics, 128(5), e1330–e1340.

Dye, B., Thornton-Evans, G., & Li, X. (2015). Dental Caries and Sealant Prevalence in Children and Adolescents in the United States, 2011–2012 (NCHS Data Brief No. 191). CDC. Final Recommendation Statement: Iron Deficiency Anemia: Screening - US Preventive Services Task Force. (2011). Retrieved May 26, 2015, from http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/iron-deficiency- anemia-screening Gilbert, S. G., & Weiss, B. (2006). A rationale for lowering the blood lead action level from 10 to 2 μg/dL. Environment and Neurodevelopmental Disorders22nd International Neurotoxicology Conference, 27(5), 693–701. http://doi.org/10.1016/j.neuro.2006.06.008 Jones, R. L., Homa, D. M., Meyer, P. A., Brody, D. J., Caldwell, K. L., Pirkle, J. L., & Brown, M. J. (2009). Trends in Blood Lead Levels and Blood Lead Testing Among US Children Aged 1 to 5 Years, 1988–2004. Pediatrics, 123(3), e376–e385. http://doi.org/10.1542/peds.2007-3608 Lozoff, B., Jimenez, E., Hagen, J., Mollen, E., & Wolf, A. W. (2000). Poorer Behavioral and Developmental Outcome More Than 10 Years After Treatment for Iron Deficiency in Infancy. Pediatrics, 105(4), e51–e51. Lozoff, B., Jimenez, E., & Smith, J. B. (2006). Double burden of iron deficiency in infancy and low socio-economic status: a longitudinal analysis of cognitive test scores to 19 years. Archives of Pediatrics & Adolescent Medicine, 160(11), 1108–1113. http://doi.org/10.1001/archpedi.160.11.1108 Navas-Acien, A., Guallar, E., Silbergeld, E. K., & Rothenberg, S. J. (2007). Lead Exposure and Cardiovascular Disease—A Systematic Review. Environmental Health Perspectives, 115(3), 472–482. http://doi.org/10.1289/ehp.9785

slide-18
SLIDE 18

10/4/2016 18

Bibliography, continued

Oregon Department of Human Services Childhood Lead Poisoning Prevention Program. (2010). State of Oregon Childhood Lead Poisoning Elimination Plan Update. Oregon Department of Human Services. Retrieved from http://library.state.or.us/repository/2010/201010181442551/index.pdf Suicide-in-Oregon-report.pdf. (2011). Retrieved May 26, 2015, from http://www.oregon.gov/oha/amh/CSAC%20Meeting%20Shedule/Suicide-in-Oregon-report.pdf Whitlock, E., O’Connor, E. A., & Williams, S. B. (2010). Effectiveness of Primary Care Interventions for Weight Management in Children and Adolescents - NCBI Bookshelf. Rockville, MD: Agency for Healthcare Research and Quality (US). Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK36416/ Williams, S. B., O’Connor, E. A., Eder, M., & Whitlock, E. P. (2009). Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task

  • Force. Pediatrics, 123(4), e716–e735. http://doi.org/10.1542/peds.2008-2415